Services

Strategic advisory across four core market gaps

Each practice draws on the same dual-engine model: senior expert judgement supported by large-scale analysis on our locally deployed AI infrastructure.

Practice 01

Research Commercialisation

Universities generate world-class science; far less of it becomes a product, a licence or a company. We work with research teams, technology transfer offices and early investors to close that gap.

  • Technology and market assessment: where a discovery can realistically compete, and against whom
  • Commercialisation pathway design — spin-out, licensing, joint development or industry partnership
  • Business-case and financing strategy for pre-seed and seed stages
  • Landscape analysis of comparable technologies, patents and competitors drawn from global data
  • Introductions to industry partners and capital where appropriate
Practice 02

SME Industrial Upgrading

Small and medium-sized enterprises often know they need to move up the value chain but are constrained by capital, talent, technology choices or market access. We help owners identify the true bottleneck and sequence the response.

  • Operational and strategic diagnostic of the business and its position in the supply chain
  • Technology adoption roadmaps, including practical, right-sized use of automation and AI
  • Product, market and channel repositioning
  • Organisation, succession and management-capability planning
  • Preparation for financing, grants and strategic partnerships
Practice 03

Biomedical Cross-Border Capital Allocation

Biomedical innovation, clinical development and capital rarely sit in the same jurisdiction. We advise companies, investors and institutions on how to allocate capital across borders with a clear view of regulatory, scientific and market realities.

  • Cross-border investment strategy and target identification for biomedical assets
  • Scientific and commercial due-diligence support, informed by large-scale literature and market analysis
  • Structuring considerations for collaborations, licensing and co-development across regions
  • Capital-raising strategy for biomedical companies seeking international investors
  • Ongoing monitoring of pipeline, competitor and policy developments
Practice 04

Global Development Planning for Top-Tier Talent

Exceptional researchers, executives and founders face choices about where to build, what to build and with whom. We provide confidential, long-range planning that treats a career as the strategic asset it is.

  • Individual positioning and multi-year development strategy
  • Assessment of international opportunities across academia, industry and entrepreneurship
  • Planning for research programmes, ventures or leadership transitions
  • Coordination with legal, tax and relocation professionals as needed
  • Discreet, principal-level engagement throughout

Not sure which practice fits?

Many engagements sit between these areas. Describe the situation and we will tell you plainly how we would approach it.

Contact us